Our findings confirm the potential of MTX, HPMCP, and chitosan nanoparticles to selectively target and internalize within cancer cells, particularly glioblastoma cells, demonstrating effective control over MTX release, biocompatibility, mucoadhesion, and inhibition of P-glycoprotein (P-gp). The gene discussed is PGP; the disease is glioblastoma.